These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 18155569)

  • 21. [[18F]-FDG-PET in the diagnostics of gastrointestinal tumors].
    Buchmann I; Ganten TM; Haberkorn U
    Z Gastroenterol; 2008 Apr; 46(4):367-75. PubMed ID: 18393156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Feasibility of (18)F-fluorodeoxyglucose positron-emission tomography for preoperative evaluation of biliary tract cancer.
    Yamada I; Ajiki T; Ueno K; Sawa H; Otsubo I; Yoshida Y; Shinzeki M; Toyama H; Matsumoto I; Fukumoto T; Nakao A; Kotani J; Ku Y
    Anticancer Res; 2012 Nov; 32(11):5105-10. PubMed ID: 23155288
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Usefulness of 18F-FDG PET in intrahepatic cholangiocarcinoma.
    Kim YJ; Yun M; Lee WJ; Kim KS; Lee JD
    Eur J Nucl Med Mol Imaging; 2003 Nov; 30(11):1467-72. PubMed ID: 14579085
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Positron tomography with 18F-fluorodeoxyglucose in the preoperative evaluation of gall bladder lesions suspicious of malignancy. Diagnostic utility and clinical impact].
    Ramos-Font C; Gómez Río M; Rodríguez-Fernández A; Sánchez Sánchez R; Llamas Elvira JM
    Rev Esp Med Nucl; 2011; 30(5):267-75. PubMed ID: 21612846
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Correlation between TNM staging of primary cholangiocarcinoma and the maximum standard uptake value of (18)F-2-deoxy-D-glucose positron emission tomography with computerized tomography].
    Wang ZF; Lan XL; Xiao YR; Liu JP; Ji JS
    Zhonghua Yi Xue Za Zhi; 2017 Oct; 97(39):3104-3107. PubMed ID: 29081157
    [No Abstract]   [Full Text] [Related]  

  • 26. Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinoma.
    Ferrone C; Goyal L; Qadan M; Gervais D; Sahani DV; Zhu AX; Hong TS; Blaszkowsky LS; Tanabe KK; Vangel M; Amorim BJ; Wo JY; Mahmood U; Pandharipande PV; Catana C; Duenas VP; Collazo YQ; Canamaque LG; Domachevsky L; Bernstine HH; Groshar D; Shih TT; Li Y; Herrmann K; Umutlu L; Rosen BR; Catalano OA
    Eur J Nucl Med Mol Imaging; 2020 Jul; 47(8):1871-1884. PubMed ID: 31705172
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical role of (18)F-FDG PET for initial staging of patients with extrahepatic bile duct cancer.
    Kato T; Tsukamoto E; Kuge Y; Katoh C; Nambu T; Nobuta A; Kondo S; Asaka M; Tamaki N
    Eur J Nucl Med Mol Imaging; 2002 Aug; 29(8):1047-54. PubMed ID: 12173019
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical usefulness of 18F-FDG PET-CT for patients with gallbladder cancer and cholangiocarcinoma.
    Lee SW; Kim HJ; Park JH; Park DI; Cho YK; Sohn CI; Jeon WK; Kim BI
    J Gastroenterol; 2010 May; 45(5):560-6. PubMed ID: 20035356
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrence-free long-term survival after liver transplantation in patients with 18F-FDG non-avid hilar cholangiocarcinoma on PET.
    Kornberg A; Küpper B; Thrum K; Wilberg J; Sappler A; Gottschild D
    Am J Transplant; 2009 Nov; 9(11):2631-6. PubMed ID: 19775312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.
    Kauhanen SP; Komar G; Seppänen MP; Dean KI; Minn HR; Kajander SA; Rinta-Kiikka I; Alanen K; Borra RJ; Puolakkainen PA; Nuutila P; Ovaska JT
    Ann Surg; 2009 Dec; 250(6):957-63. PubMed ID: 19687736
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Usefulness of Preoperative
    Ikeno Y; Seo S; Yamamoto G; Nakamoto Y; Uemoto Y; Fuji H; Yoshino K; Yoh T; Taura K; Uemoto S
    Anticancer Res; 2018 Jun; 38(6):3677-3682. PubMed ID: 29848727
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of 18F-fluorodeoxyglucose positron emission tomography in detecting extrahepatic metastasis in pretreatment staging of hepatocellular carcinoma.
    Yoon KT; Kim JK; Kim DY; Ahn SH; Lee JD; Yun M; Rha SY; Chon CY; Han KH
    Oncology; 2007; 72 Suppl 1():104-10. PubMed ID: 18087190
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical usefulness of 18-fluorodeoxyglucose positron emission tomography in the management of patients with nonpancreatic periampullary neoplasms.
    Sperti C; Pasquali C; Fiore V; Bissoli S; Chierichetti F; Liessi G; Pedrazzoli S
    Am J Surg; 2006 Jun; 191(6):743-8. PubMed ID: 16720142
    [TBL] [Abstract][Full Text] [Related]  

  • 34. FDG PET in the diagnosis of hilar cholangiocarcinoma.
    Fritscher-Ravens A; Bohuslavizki KH; Broering DC; Jenicke L; Schäfer H; Buchert R; Rogiers X; Clausen M
    Nucl Med Commun; 2001 Dec; 22(12):1277-85. PubMed ID: 11711897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of (18) F-fluorodeoxyglucose (FDG)-positron-emission tomography/computed tomography (PET/CT) on management of patients with carcinoma invading bladder muscle.
    Mertens LS; Fioole-Bruining A; Vegt E; Vogel WV; van Rhijn BW; Horenblas S
    BJU Int; 2013 Oct; 112(6):729-34. PubMed ID: 23790129
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is combined 18F-fluorodeoxyglucose-positron emission tomography/computed tomography superior to positron emission tomography or computed tomography alone for diagnosis, staging and restaging of pancreatic lesions?
    Casneuf V; Delrue L; Kelles A; Van Damme N; Van Huysse J; Berrevoet F; De Vos M; Duyck P; Peeters M
    Acta Gastroenterol Belg; 2007; 70(4):331-8. PubMed ID: 18330088
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Significance of fluorodeoxyglucose PET imaging in the diagnosis of malignancies in patients with biliary stricture.
    Wakabayashi H; Akamoto S; Yachida S; Okano K; Izuishi K; Nishiyama Y; Maeta H
    Eur J Surg Oncol; 2005 Dec; 31(10):1175-9. PubMed ID: 16019182
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of (18)F-fluorodeoxyglucose positron emission tomography in patients with extrahepatic bile duct cancer.
    Kitamura K; Hatano E; Higashi T; Seo S; Nakamoto Y; Narita M; Taura K; Yasuchika K; Nitta T; Yamanaka K; Doi R; Ikai I; Uemoto S
    J Hepatobiliary Pancreat Sci; 2011 Jan; 18(1):39-46. PubMed ID: 20503059
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Surgery for Recurrent Biliary Tract Cancer: A Single-center Experience With 74 Consecutive Resections.
    Takahashi Y; Ebata T; Yokoyama Y; Igami T; Sugawara G; Mizuno T; Nimura Y; Nagino M
    Ann Surg; 2015 Jul; 262(1):121-9. PubMed ID: 25405563
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Preoperative assessment of hilar cholangiocarcinoma by dual-modality PET/CT.
    Li J; Kuehl H; Grabellus F; Müller SP; Radunz S; Antoch G; Nadalin S; Broelsch CE; Gerken G; Paul A; Kaiser GM
    J Surg Oncol; 2008 Nov; 98(6):438-43. PubMed ID: 18767120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.